跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
LUPIN-TIOTROPIUM
Authorized
STANDARD
LUPIN-TIOTROPIUM
lupin pharma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9d8370acb719b18f
Company
lupin pharma canada limited
Type
Standard
Approval Details
Approval Id
9d8370acb719b18f
Drug Approval Canada Name
LUPIN-TIOTROPIUM
Product Name
LUPIN-TIOTROPIUM
Status
Marketed
Status Date
2023-12-18
Original Market Date
2023-12-18
Din
02537850
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Inhalation
Schedule
Prescription
Ahfs
12:08.08
Atc Original
R03BB04 TIOTROPIUM BROMIDE
Atc Name
r 03 bb 04
Aig Number
0148683001
Company Name
lupin pharma canada limited
Company Address
550-1111 Rue St-Charles Ouest, Longueuil, Quebec, Canada, J4K 5G4
Active Ingredients
TIOTROPIUM (TIOTROPIUM BROMIDE MONOHYDRATE)
18 MCG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9d8370acb719b18f
Type
Standard
Back to Health Canada Approvals
LUPIN-TIOTROPIUM - Health Canada Drug Approval Details